Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- USWM CT, LLC
- Study ID
- NCT03391778
- Phase
- PHASE1
- Status
- Enrolling By Invitation
Conditions
- Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ADP adoptive cell therapy — BIOLOGICALNo study drug is administered in this study. Participants who received ADP adoptive cell therapy in a previous trial will be evaluated in this trial for long-term safety and efficacy.
Study Details
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Key Dates
- First listed
- Jan 5, 2018
- Start date
- Apr 9, 2018
- Status verified
- Feb 2026
- Primary completion
- Apr 1, 2032
- Completion
- Apr 1, 2032
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Participants receiving ADP adoptive cell therapy
Primary Outcome Measure
Number of participants with delayed adverse events (AEs) and serious adverse events (SAEs) [ Time Frame: 15 years post last treatment ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University School of Medicine | Atlanta | Georgia | 30322 | - |
| ADP Investigational Site | Baltimore | Maryland | 21201 | - |
| National Cancer Institute - Center for Cancer Research | Bethesda | Maryland | 20892 | - |
| University of Michigan | Ann Arbor | Michigan | 48109 | - |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | - |
| Memorial Sloan Kettering Cancer Center - New York | New York | New York | 10065 | - |
| Duke University Medical Center | Durham | North Carolina | 27710 | - |
| Oregon Health and Science University | Portland | Oregon | 97239 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | - |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | - |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | - |
| Froedtert Hospital | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Atlanta, GA
By research site
Emory University School of Medicine· Atlanta, GAADP Investigational Site· Baltimore, MDNational Cancer Institute - Center for Cancer Research· Bethesda, MDUniversity of Michigan· Ann Arbor, MIWashington University School of Medicine in St. Louis· St Louis, MOMemorial Sloan Kettering Cancer Center - New York· New York, NY
Related Studies
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersEnrolling By Invitation · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Barrett's Esophagus Related Neoplasia (BERN) ProjectRecruiting · Midwest Biomedical Research · Kansas City, Missouri
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Atlanta, Georgia
- Data Collection, Clinical Care and Interventions in CCR, NCIEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland